|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/56 | (2006.01) |
| C07K 16/2896 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| A61K 38/21 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/41 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| C07K2319/00 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 38/212 | (2013.01) | ||
| C07K 14/56 | (2013.01) | ||
| C07K2317/56 | (2013.01) | ||
| C07K2319/74 | (2013.01) |
| (11) | Number of the document | 3677591 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19213030.0 |
| Date of filing the European patent application | 2013-04-29 | |
| (97) | Date of publication of the European application | 2020-07-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-28 |
| (46) | Date of publication of the claims translation |
| (72) |
CLARKE, Adam , AU
POLLARD, Matthew , AU
DOYLE, Anthony, Gerard , AU
BEHRENS, Collette , AU
YAMAGISHI, Tetsuo , AU
WILSON, David, S. Jr. , US
POGUE, Sarah, L. , US
TAURA, Tetsuya , US
|
| (73) |
Teva Pharmaceuticals Australia Pty Ltd ,
Level 2
37 Epping Road, Macquarie Park, NSW 2113,
AU
|
| (54) | ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B |
| ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B |